FHD-286 is a BRG1/BRM ATPase inhibitor, which is associated with tumor development and progression. SMILES: CC1CN(CC(O1)C)C2=CC=CC(=N2)C3=CSC(=N3)NC(=O)C(COC)NC(=O)C4=CN(C=C4)S(=O)(=O)C

Description: FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia. Target: Epigenetic Reader Domain. Smiles: COC[C@H](NC(=O)c1ccn(c1)S(C)(=O)=O)C(=O)Nc1nc(cs1)-c1cccc(n1)N1C[C@H](C)O[C@H](C)C1. References: Centore, Richard C....